Journal Title：Expert Review Of Hematology

Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.

近年來，先進的分子研究技術已經改變了血液學。隨著對血液病的了解不斷加深，我們現在有機會研究和評估新的生物療法、新藥物和藥物組合、新的治療方案和包括干細胞移植在內的新方法。我們還可以期待蛋白質組學、分子遺傳學和生物標志物研究能夠促進新的診斷方法和適當療法的識別。我們對血細胞和造血組織的形成和功能的認識將進一步提高，對于血液學家來說，采用這些新模式并制定綜合策略來確定最佳的患者護理將是一個重大挑戰。《血液學專家評論》（1747-4086）將這些進展放在背景中，并探討它們將如何直接轉化為臨床實踐。

Expert Review Of Hematology創刊于2008年，由Taylor and Francis Ltd.出版商出版，收稿方向涵蓋HEMATOLOGY全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 較慢,6-12周 ，影響因子指數2.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。